Identification and Characterization of Angiogenesis Targets through Proteomic Profiling of Endothelial Cells in Human Cancer Tissues

被引:35
作者
Mesri, Mehdi [1 ]
Birse, Charlie [1 ]
Heidbrink, Jenny [1 ]
McKinnon, Kathy [1 ]
Brand, Erin [1 ]
Bermingham, Candy Lee [1 ]
Feild, Brian [1 ]
FitzHugh, William [1 ]
He, Tao [1 ]
Ruben, Steve [1 ]
Moore, Paul A. [1 ]
机构
[1] Celera, Alameda, CA USA
关键词
TUMOR ANGIOGENESIS; THY-1; CD90; GENES; VASCULATURE; ADHESION; VESSELS; B7-H3; CD146;
D O I
10.1371/journal.pone.0078885
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Genomic and proteomic analysis of normal and cancer tissues has yielded abundant molecular information for potential biomarker and therapeutic targets. Considering potential advantages in accessibility to pharmacological intervention, identification of targets resident on the vascular endothelium within tumors is particularly attractive. By employing mass spectrometry (MS) as a tool to identify proteins that are over-expressed in tumor-associated endothelium relative to normal cells, we aimed to discover targets that could be utilized in tumor angiogenesis cancer therapy. We developed proteomic methods that allowed us to focus our studies on the discovery of cell surface/secreted proteins, as they represent key antibody therapeutic and biomarker opportunities. First, we isolated endothelial cells (ECs) from human normal and kidney cancer tissues by FACS using CD146 as a marker. Additionally, dispersed human colon and lung cancer tissues and their corresponding normal tissues were cultured ex-vivo and their endothelial content were preferentially expanded, isolated and passaged. Cell surface proteins were then preferentially captured, digested with trypsin and subjected to MS-based proteomic analysis. Peptides were first quantified, and then the sequences of differentially expressed peptides were resolved by MS analysis. A total of 127 unique non-overlapped (157 total) tumor endothelial cell over-expressed proteins identified from directly isolated kidney-associated ECs and those identified from ex-vivo cultured lung and colon tissues including known EC markers such as CD146, CD31, and VWF. The expression analyses of a panel of the identified targets were confirmed by immunohistochemistry (IHC) including CD146, B7H3, Thy-1 and ATP1B3. To determine if the proteins identified mediate any functional role, we performed siRNA studies which led to previously unidentified functional dependency for B7H3 and ATP1B3.
引用
收藏
页数:12
相关论文
共 34 条
[1]  
Ahlskog J, 2006, Q J NUCL MED MOL IM, V50, P296
[2]   The human plasma proteome - History, character, and diagnostic prospects [J].
Anderson, NL ;
Anderson, NG .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (11) :845-867
[3]   Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J].
Arap, W ;
Pasqualini, R ;
Ruoslahti, E .
SCIENCE, 1998, 279 (5349) :377-380
[4]  
BOBBITT JM, 1956, ADV CARBOHYD CHEM, V11, P1
[5]   A chemical proteomics approach for the identification of accessible antigens expressed in human kidney cancer [J].
Castronovo, Vincent ;
Waltregny, David ;
Kischel, Philippe ;
Roesli, Christoph ;
Elia, Giuliano ;
Rybak, Jascha-N. ;
Neri, Dario .
MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (11) :2083-2091
[6]   B7-H3:: A costimulatory molecule for T cell activation and IFN-γ production [J].
Chapoval, AI ;
Ni, J ;
Lau, JS ;
Wilcox, RA ;
Flies, DB ;
Liu, D ;
Dong, HD ;
Sica, GL ;
Zhu, GF ;
Tamada, K ;
Chen, LP .
NATURE IMMUNOLOGY, 2001, 2 (03) :269-274
[7]   THE IDENTIFICATION OF PROLIFERATION AND TUMOR-INDUCED PROTEINS IN HUMAN ENDOTHELIAL-CELLS - A POSSIBLE TARGET FOR TUMOR-THERAPY [J].
CLARKE, MSF ;
WEST, DC .
ELECTROPHORESIS, 1991, 12 (7-8) :500-508
[8]   Angiogenesis as a therapeutic target [J].
Ferrara, N ;
Kerbel, RS .
NATURE, 2005, 438 (7070) :967-974
[9]  
He J, 2011, MOL CELL PROTEOMICS
[10]   In silico cloning of novel endothelial-specific genes [J].
Huminiecki, L ;
Bicknell, R .
GENOME RESEARCH, 2000, 10 (11) :1796-1806